title: Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
authors.forename: Ferenc
authors.initials: F
authors.lastname: Izbéki
authors.forename: Ferenc
authors.initials: F
authors.lastname: Nagy
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szepes
authors.forename: Ildikó
authors.initials: I
authors.lastname: Kiss
authors.forename: János
authors.initials: J
authors.lastname: Lonovics
authors.forename: Tamás
authors.initials: T
authors.lastname: Molnár
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008584:Meningitis, Listeria / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism; D008875:Middle Aged; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab